https://www.selleckchem.com/pr....oducts/(-)-Epigalloc
MNTI is a rare tumor of indeterminate histogenesis and molecular signature. We performed methylation and copy number variation (CNV) profiles in patients with MNTI (n = 7) and PAT (n = 1) compared to the methylation brain tumor classifier v11b4 (BT-C) and the medulloblastoma (M classifier group 3/4 v1.0 (MB3/4-C). The patients' mean age was 8 months (range 4-48). The BT-C classified five MNTIs and one PAT (relapse) as class family MB-G3/G4, subclass group 3 (score 0.9). The remaining two MNTIs and PAT (primary
Like
Comment
Share
